TO THE EDITOR: We just witnessed an interesting debate, with lowdown punches, on the potential role of airway smooth muscle (ASM) in asthmatic airway hyperresponsiveness (AHR) when the ASM proponents Drs. Gunst and Panettieri faced the ASM opponents Drs. Paré and Mitzner (2). However, part of the disagreement seems to lie upon the vocabulary used. On one hand, the proponents reported that several molecules that are overexpressed in asthma have the ability to affect ASM contractility. IL-17A can now be added to this list (3). These observations suggest that the contractile properties of ASM are malleable. In asthmatic lungs, where the ASM is bombarded by many of those molecules, it seems reasonable to infer that the ASM may become stronger, stiffer, quicker, and/or less likely to relax, which may all contribute to AHR. On the other hand, the opponents can argue that nonasthmatic ASM would behave similarly under these aberrant circumstances. Therefore, the ASM of asthmatics is not abnormal. The term "alterations" in the title of this debate is a source of ambiguity, because it can either mean that the alterations are innate (genetically determined) or acquired due to both the abnormal environment in which asthmatic ASM operates and the recognized malleability of ASM contractility. If my little 10 years of experience is worth anything, I don't think there is convincing evidence of innate differences in contractility between asthmatic and non-asthmatic ASM in humans. The hypercontractile phenotype observed by Ma et al. (4) Alterations in airway smooth muscle phenotype do/do not cause airway hyperresponsiveness in asthma.
TO THE EDITOR: We just witnessed an interesting debate, with lowdown punches, on the potential role of airway smooth muscle (ASM) in asthmatic airway hyperresponsiveness (AHR) when the ASM proponents Drs. Gunst and Panettieri faced the ASM opponents Drs. Paré and Mitzner (2) . However, part of the disagreement seems to lie upon the vocabulary used. On one hand, the proponents reported that several molecules that are overexpressed in asthma have the ability to affect ASM contractility. IL-17A can now be added to this list (3) . These observations suggest that the contractile properties of ASM are malleable. In asthmatic lungs, where the ASM is bombarded by many of those molecules, it seems reasonable to infer that the ASM may become stronger, stiffer, quicker, and/or less likely to relax, which may all contribute to AHR. On the other hand, the opponents can argue that nonasthmatic ASM would behave similarly under these aberrant circumstances. Therefore, the ASM of asthmatics is not abnormal. The term "alterations" in the title of this debate is a source of ambiguity, because it can either mean that the alterations are innate (genetically determined) or acquired due to both the abnormal environment in which asthmatic ASM operates and the recognized malleability of ASM contractility. If my little 10 years of experience is worth anything, I don't think there is convincing evidence of innate differences in contractility between asthmatic and non-asthmatic ASM in humans. The hypercontractile phenotype observed by Ma et al. (4) , Matsumoto et al. (5) , and more recently Sutcliffe et al. (6) in isolated cells could have been acquired and simply maintained in culture; not mentioning that those findings are plagued with the lack of consistency (1). The acute inflammation is usually accompanied by the preponderance of diverse immune cells and cytokines, whereas the chronic form is associated with irreversible morphological alterations, including deposition of collagen and fibronectin with hypertrophy and hyperplasia of ASM leaving a profound impact on AHR (3).
ASM phenotype plasticity characterized by reversible switching between contractile and proliferative phenotypes was reported to have contributed to airway remodeling and AHR (1). Additionally, increased expression of PDE4D in asthma patients appears to be independent of inflammation, resulting in suboptimal dilation of airways. A thorough histological and morphometric examination of all the airway layers during asthma might reveal the whole cartel of accomplices, but the cardinal medium for AHR is purported to be ASM. 6 (3) . Similarly, PGE 2 seems to regulate intracellular 3=-5=-cyclic adenosine monophosphate (cAMP), which governs multiple aspects of ASM function (2) . Again, the airway smooth muscle proliferation (6) could be regulated by PGE 2 as well. It is likely that the COX pathway may produce both smooth muscle relaxant (PGI 2 and PGE 2 ) and contracting PGs, i.e., thromboxane A2 (TxA2) and PGF2 (PGF2) in ASM cells (5) as they do in vascular smooth muscle cells. Hence, the ASM phenotype could be dependent on the COX-mediated inflammation, and AHR might be in intricate balance of these contrasting PGs. Therefore, an understanding about the role of PGs and their specific receptors in ASM will be an immensely important aspect to identify novel therapeutic targets and to develop newer drugs for the treatment and prevention of asthma (1).
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ON THE ONE HAND, ON THE OTHER HAND
TO THE EDITOR: Since the definition of phenotype is "the observable physical or biochemical characteristics of an organism, as determined by both genetic makeup and environmental influences," it could be argued that both approaches in these two articles are correct-one "pointing the finger" at intrinsic abnormalities and the other apportioning "blame" to the environment or milieu. Another point in favor of a "both have merits" response is that each group of authors has been even handed in their citing of articles from our group-8/45 in the case of Drs. Gunst and Panettieri (3) and 7/32 from Drs. Paré and Mitzner (4). This displays an admirable and equal appreciation of critical aspects of the literature by both sets of combatants! Two points in the Paré/Mitzner article provoke comment. First, they describe maximal shortening in airway smooth muscle cells from asthmatic subjects as 25-49% of initial length and state that this is much less than that of the maximal shortening of "human airway smooth muscle strips-75%" Chin et al. (1, 2) . Horror!! These studies using strips were conducted in tracheae-an unlikely area of the respiratory tree to have relevance for human asthma. Second, they suggest that the airway smooth muscle "reverts to . . . a more synthetic . . . " and "perhaps even less contractile phenotype." The implication is that muscle can do one thing or the other. As we have said on many an occasion, the smooth muscle is a woman and therefore can do everything (5) TO THE EDITOR: As obvious from the preceding exchanges between our experienced, although still forever young colleagues, there is a clear agreement regarding the existence of phenotypic changes in asthmatic airway smooth muscle (ASM) (4, 5) , such as increased ASM mass, proliferation, migration, extracellular matrix, and cytokines production . . . The remaining question is thus whether these phenotypic alterations directly relate to AHR. In this framework, one should consider that ASM is obviously guilty but it also has a variety of accomplices in the milieu. An illustration of this balanced statement would be the cross talk between ASM and other critical cells in asthma. For instance, in addition to exhibiting fundamental intrinsic abnormalities relating to AHR such as altered calcium homeostasis (6), asthmatic ASM can influence its milieu by directly recruiting mast cells (2) whose adhesion is increased in asthma (3). Mast cells then stimulate ASM, which in turn recruit additional mast cells, thus generating an auto-activation loop (2) . Conversely, another important structural cell in the milieu in asthma, the epithelial cell, influences ASM. Indeed, we recently demonstrated that epithelium-derived YKL-40 increased ASM proliferation and migration, particularly using asthmatic ASM cells (1) . Therefore, the actual question our experienced although enthusiastic colleagues should now deal with, is how much of AHR should be ascribed to ASM phenotype and how much to the milieu, i.e., acting as talented physiologists, moving from a qualitative to a quantitative issue.
